DB
DCVC Bio invests in early-stage deep tech startups within the life sciences, focusing on computation-enhanced platforms that leverage AI and big data to generate new categories of treatments and products. Their strategy involves backing scientific teams that address critical health and environmental challenges, such as curing diseases, extending healthy lifespans, and producing sustainable food.
Portfolio
3
Fund Size
$1B
Top Stage
Series A
Last 12 Mo
0
Stage Distribution
Portfolio
3 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Umoja Biopharma, Inc. | Series C | $100M | Jan 2025 |
| Elo Life Systems | Series A | $20.5M | Jan 2024 |
| Elo Life Systems | Series A | $24.5M | Feb 2023 |
Top Co-Investors
SoftBank Vision Fund1 shared
Novo Holdings1 shared
AccelR81 shared
Alexandria Venture Investments1 shared
Last updated: 26 February 2026